通过自来准神经退行性疾病的新前景
Shumayila Khan1, Saurabh Upadhyay2, Md Imtaiyaz Hassan3
1International Health Division, Indian Council of Medical Research, Ansari Nagar, New Delhi, 110029, India.
European journal of pharmacology
|October 19, 2024
概括
蛋白质聚合会导致神经退行性疾病. 这篇评论探讨了新的策略,如基因调制和纳米粒子来增强神经保护的自,提供新的治疗途径.
科学领域:
- 神经科学是一个神经科学.
- 细胞生物学 细胞生物学
- 生物化学 生物化学
背景情况:
- 蛋白质聚合,神经退行性疾病的标志,由蛋白质稳定不平衡引起.
- 自,一种细胞降解途径,是清除有毒蛋白质聚合物的关键目标.
- 目前的小分子疗法尽管在临床前取得了成功,但其临床转化能力有限.
研究的目的:
- 审查在神经退行性疾病中调节自的新兴策略.
- 要突出超越传统药物输送的神经保护的新方法.
- 讨论自性向神经退行性疗法的挑战和未来方向.
主要方法:
- 对当前和新兴的自细胞调节策略的文献综述.
- 对增强自的基因表达调制技术的分析.
- 纳米粒子物理化学性质的探索用于直接自诱导.
主要成果:
- 小分子方法面临临床翻译的挑战.
- 基因表达调制提供了一个有前途的神经保护策略.
- 诱导自的纳米颗粒提供了一个新的,无药的治疗途径.
结论:
- 像基因调制和直接纳米粒子诱导自等新策略在神经退行性疾病治疗中具有显著的潜力.
- 克服临床翻译障碍需要创新的方法.
- 未来的研究应该专注于改进这些方法以获得有效的神经保护.
相关概念视频
Autophagy
4.2K
Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
4.2K
Delivery Pathways to the Lysosome
6.2K
Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
6.2K
Parkinson's Disease: Overview
486
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
486
Autophagic Cell Death
3.4K
Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
3.4K
Lysosomal Hydrolases
3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K
The Proteasome
815
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
815


